Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRTS
DateTimeSourceHeadlineSymbolCompany
01/05/202422:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
25/03/202423:50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
08/03/202408:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
08/03/202408:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
08/03/202408:01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
27/02/202400:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
27/02/202400:30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
21/12/202301:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
21/12/202301:15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
19/12/202303:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
30/11/202300:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
30/11/202300:30GlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202300:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202300:30GlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSAlpha Tau Medical Ltd
21/11/202322:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
21/11/202300:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
21/11/202300:30GlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSAlpha Tau Medical Ltd
17/11/202308:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
17/11/202308:30GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
02/11/202308:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
01/11/202323:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
30/10/202323:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
30/10/202323:30GlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSAlpha Tau Medical Ltd
25/10/202300:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
25/10/202300:00GlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSAlpha Tau Medical Ltd
27/09/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
25/09/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRTSAlpha Tau Medical Ltd
14/09/202322:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
14/09/202322:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterNASDAQ:DRTSAlpha Tau Medical Ltd
12/09/202306:16Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:DRTSAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTS